APA (7th ed.) Citation

JM, J., TL, B., C, C., SM, S., FV, F., ZA, A., . . . PB, C. (2019). Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials. Cancer, 125(1), 18. https://doi.org/10.1002/cncr.31719

Chicago Style (17th ed.) Citation

JM, Jeter, et al. "Chemoprevention Agents for Melanoma: A Path Forward into Phase 3 Clinical Trials." Cancer 125, no. 1 (2019): 18. https://doi.org/10.1002/cncr.31719.

MLA (9th ed.) Citation

JM, Jeter, et al. "Chemoprevention Agents for Melanoma: A Path Forward into Phase 3 Clinical Trials." Cancer, vol. 125, no. 1, 2019, p. 18, https://doi.org/10.1002/cncr.31719.